Skip to content

Clinical trials

Completed Phase 1/2 trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 1/2 Status: Completed Country / region: New Zealand Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20051
20061
20081
20091
20103
20111
20133
20141
20161
20172
20183
20204
20222
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Arrowhead Pharmaceuticals5
Merck Sharp & Dohme LLC3
Teva Branded Pharmaceutical Products R&D, Inc.2
Amicus Therapeutics1
Antiva Biosciences1
Australian and New Zealand Intensive Care Research Centre1
BeiGene1
Bristol-Myers Squibb1
Diatranz Otsuka Limited1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Asthma2
Carcinoma, Renal Cell2
Hepatitis B2
Pulmonary Disease, Chronic Obstructive2
Acute Lung Injury1
Back Pain1
Critical Illness1
Diabetes Mellitus, Type 11
Encephalitis, Japanese1
Glomerulonephritis, IGA1

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.